Clinical Trials
Inovio Announces Analysis Of VGX-3100 Phase 2b Data
Inovio Pharmaceuticals, Inc announced that post-hoc analysis of data generated from its phase 2b trial of VGX-3100 identified immune correlates and biomarker signatures predictive of...
Clinical Trials
OSE Immunotherapeutics to Resume Accrual in Phase 3 Clinical...
OSE Immunotherapeutics announces that the Independent Data Monitoring Committee (IDMC) has recommended to the trial’s steering committee that accrual of the Tedopi® Phase 3 trial...
Clinical Trials
CRF Health’s TrialMax Touch® Selected by Leading Specialty Pharmaceutical...
CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, has been selected by a leading specialty...
Clinical Trials
Cmed to Demonstrate how encapsia® Transforms Clinical Trial Data...
Cmed, an oncology focused, innovative technology-led CRO, announced that it will showcase its encapsia® clinical data suite at two leading oncology meetings, Clinical Operations in...
Articles
Direct-to-Patient Solutions Assuring Patient Participation and Retention in Clinical...
The average cost of bringing a new drug to market is $2.6 billion, according to a 2014 report published by Tufts Center for the Study...
Clinical Trials
Cmed to Showcase Advanced Data Insights and Analytics Capabilities...
Cmed, an innovative technology-led CRO, will demonstrate its encapsia® clinical data suite at Partnerships in Clinical Trials Europe, taking place 28-29 November 2017 in Amsterdam,...
Articles
Asia’s increasing levels of clinical trial industry competition are...
Biotechnology and pharmaceutical companies within the United States and Europe face an increasing number of hurdles when undertaking clinical trials within their own country or region; problems such as over...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.